Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Protagonist Therapeutics (PTGX) Interest Expenses (2020)

Protagonist Therapeutics (PTGX) has disclosed Interest Expenses for 1 consecutive years, with $127000.0 as the latest value for Q4 2020.

  • Quarterly Interest Expenses changed N/A to $127000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $127000.0 through Sep 2021, down 73.04% year-over-year, with the annual reading at $598000.0 for FY2020, 253.85% up from the prior year.
  • Interest Expenses hit $127000.0 in Q4 2020 for Protagonist Therapeutics, up from $19000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $243000.0 in Q1 2020 to a low of $19000.0 in Q3 2020.